High yield expression of leptospirosis vaccine candidates LigA and LipL32 in the methylotrophic yeast Pichia pastoris

Microbial Cell Factories

Volumn 9, Issue , 2010, Pages

  Hartwig, Daiane D ^a   Oliveira, Thaís L ^a   Seixas, Fabiana K ^a   Forster, Karine M ^a   Rizzi, Caroline ^a   Hartleben, Cláudia P ^a   McBride, Alan J A ^b   Dellagostin, Odir A ^a  

^a FEDERAL UNIVERSITY OF PELOTAS   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; LEPTOSPIROSIS VACCINE; OUTER MEMBRANE PROTEIN; OUTER MEMBRANE PROTEIN LIGA; OUTER MEMBRANE PROTEIN LIPL32; RECOMBINANT PROTEIN; RECOMBINANT PROTEIN LIGA; RECOMBINANT PROTEIN LIPL32; SECRETORY PROTEIN; UNCLASSIFIED DRUG; BACTERIAL PROTEIN; BACTERIAL VACCINE; LIPL32 PROTEIN, LEPTOSPIRA; LIPOPROTEIN; SUBUNIT VACCINE;

ANTIGENICITY; ARTICLE; BLOOD SAFETY; CONTROLLED STUDY; DISEASE SEVERITY; DRUG PURIFICATION; GENE EXPRESSION; GLYCOSYLATION; HUMAN; LARGE SCALE PRODUCTION; LEPTOSPIROSIS; METHYLOTROPHIC YEAST; NUCLEOTIDE SEQUENCE; PICHIA PASTORIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; VACCINE PRODUCTION; ENZYMOLOGY; GENETICS; IMMUNOLOGY; LEPTOSPIRA; METABOLISM; PICHIA;

ESCHERICHIA COLI; LEPTOSPIRA; LIGA; PICHIA PASTORIS;

BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL PROTEINS; BACTERIAL VACCINES; GLYCOSYLATION; HUMANS; LEPTOSPIRA; LEPTOSPIROSIS; LIPOPROTEINS; PICHIA; RECOMBINANT PROTEINS; VACCINES, SUBUNIT;

EID: 78649690371     PISSN: None     EISSN: 14752859     Source Type: Journal    
DOI: 10.1186/1475-2859-9-98     Document Type: Article

References (35)

1. Bharti AR, Nally JE, Ricaldi JN, Matthias MA, Diaz MM, Lovett MA, Levett PN, Gilman RH, Willig MR, Gotuzzo E, et al. Leptospirosis: a zoonotic disease of global importance. Lancet Infect Dis 2003, 3(12):757-771. 10.1016/S1473-3099(03)00830-2, 14652202.
2. Adler B, de la Pena Moctezuma A. Leptospira and leptospirosis. Vet Microbiol 2010, 140(3-4):287-296. 10.1016/j.vetmic.2009.03.012, 19345023.
3. Faine SB, Adler B, Bolin C, Perolat P. Leptospira and leptospirosis. 1999, Melbourne: MediSci, 2.
4. Reis RB, Ribeiro GS, Felzemburgh RD, Santana FS, Mohr S, Melendez AX, Queiroz A, Santos AC, Ravines RR, Tassinari WS, et al. Impact of environment and social gradient on leptospira infection in urban slums. PLoS Negl Trop Dis 2008, 2(4):e228. 10.1371/journal.pntd.0000228, 2292260, 18431445.
5. McBride AJ, Athanazio DA, Reis MG, Ko AI. Leptospirosis. Curr Opin Infect Dis 2005, 18(5):376-386. 10.1097/01.qco.0000178824.05715.2c, 16148523.
6. Gouveia EL, Metcalfe J, de Carvalho AL, Aires TS, Villasboas-Bisneto JC, Queirroz A, Santos AC, Salgado K, Reis MG, Ko AI. Leptospirosis-associated Severe Pulmonary Hemorrhagic Syndrome, Salvador, Brazil. Emerg Infect Dis 2008, 14(3):505-508. 10.3201/eid1403.071064, 2570821, 18325275.
7. Segura ER, Ganoza CA, Campos K, Ricaldi JN, Torres S, Silva H, Cespedes MJ, Matthias MA, Swancutt MA, Lopez Linan R, et al. Clinical spectrum of pulmonary involvement in leptospirosis in a region of endemicity, with quantification of leptospiral burden. Clin Infect Dis 2005, 40(3):343-351. 10.1086/427110, 2366057, 15668855.
8. Haake DA, Mazel MK, McCoy AM, Milward F, Chao G, Matsunaga J, Wagar EA. Leptospiral outer membrane proteins OmpL1 and LipL41 exhibit synergistic immunoprotection. Infect Immun 1999, 67(12):6572-6582. 97069, 10569777.
9. Yan W, Faisal SM, McDonough SP, Chang CF, Pan MJ, Akey B, Chang YF. Identification and characterization of OmpA-like proteins as novel vaccine candidates for Leptospirosis. Vaccine 2010, 28(11):2277-2283. 10.1016/j.vaccine.2009.12.071, 20064477.
10. Wang Z, Jin L, Wegrzyn A. Leptospirosis vaccines. Microb Cell Fact 2007, 6:39. 10.1186/1475-2859-6-39, 2231387, 18072968.
11. Koizumi N, Watanabe H. Leptospiral immunoglobulin-like proteins elicit protective immunity. Vaccine 2004, 22(11-12):1545-1552. 10.1016/j.vaccine.2003.10.007, 15063580.
12. Yan W, Faisal SM, McDonough SP, Divers TJ, Barr SC, Chang CF, Pan MJ, Chang YF. Immunogenicity and protective efficacy of recombinant Leptospira immunoglobulin-like protein B (rLigB) in a hamster challenge model. Microbes Infect 2009, 11(2):230-237. 10.1016/j.micinf.2008.11.008, 19070678.
13. Silva EF, Medeiros MA, McBride AJ, Matsunaga J, Esteves GS, Ramos JG, Santos CS, Croda J, Homma A, Dellagostin OA, et al. The terminal portion of leptospiral immunoglobulin-like protein LigA confers protective immunity against lethal infection in the hamster model of leptospirosis. Vaccine 2007, 25(33):6277-6286. 10.1016/j.vaccine.2007.05.053, 1994161, 17629368.
14. Palaniappan RU, McDonough SP, Divers TJ, Chen CS, Pan MJ, Matsumoto M, Chang YF. Immunoprotection of recombinant leptospiral immunoglobulin-like protein A against Leptospira interrogans serovar Pomona infection. Infect Immun 2006, 74(3):1745-1750. 10.1128/IAI.74.3.1745-1750.2006, 1418682, 16495547.
15. Feng CY, Li QT, Zhang XY, Dong K, Hu BY, Guo XK. Immune strategies using single-component LipL32 and multi-component recombinant LipL32-41-OmpL1 vaccines against leptospira. Braz J Med Biol Res 2009, 42(9):796-803. 10.1590/S0100-879X2009005000013, 19649391.
16. Seixas FK, da Silva EF, Hartwig DD, Cerqueira GM, Amaral M, Fagundes MQ, Dossa RG, Dellagostin OA. Recombinant Mycobacterium bovis BCG expressing the LipL32 antigen of Leptospira interrogans protects hamsters from challenge. Vaccine 2007, 26(1):88-95. 10.1016/j.vaccine.2007.10.052, 18063449.
17. Branger C, Chatrenet B, Gauvrit A, Aviat F, Aubert A, Bach JM, Andre-Fontaine G. Protection against Leptospira interrogans sensu lato challenge by DNA immunization with the gene encoding hemolysin-associated protein 1. Infect Immun 2005, 73(7):4062-4069. 10.1128/IAI.73.7.4062-4069.2005, 1168576, 15972494.
18. Sonrier C, Branger C, Michel V, Ruvoen-Clouet N, Ganiere JP, Andre-Fontaine G. Evidence of cross-protection within Leptospira interrogans in an experimental model. Vaccine 2000, 19(1):86-94. 10.1016/S0264-410X(00)00129-8, 10924790.
19. Sorensen HP. Towards universal systems for recombinant gene expression. Microb Cell Fact 2010, 9:27. 10.1186/1475-2859-9-27, 2876075, 20433754.
20. Cos O, Ramon R, Montesinos JL, Valero F. Operational strategies, monitoring and control of heterologous protein production in the methylotrophic yeast Pichia pastoris under different promoters: a review. Microb Cell Fact 2006, 5:17. 10.1186/1475-2859-5-17, 1564409, 16600031.
21. Cregg JM, Cereghino JL, Shi J, Higgins DR. Recombinant protein expression in Pichia pastoris. Mol Biotechnol 2000, 16(1):23-52. 10.1385/MB:16:1:23, 11098467.
22. Faisal SM, Yan W, Chen CS, Palaniappan RU, McDonough SP, Chang YF. Evaluation of protective immunity of Leptospira immunoglobulin like protein A (LigA) DNA vaccine against challenge in hamsters. Vaccine 2008, 26(2):277-287. 10.1016/j.vaccine.2007.10.029, 18055070.
23. Faisal SM, Yan W, McDonough SP, Chang YF. Leptospira immunoglobulin-like protein A variable region (LigAvar) incorporated in liposomes and PLGA microspheres produces a robust immune response correlating to protective immunity. Vaccine 2009, 27(3):378-387. 10.1016/j.vaccine.2008.10.089, 19022317.
24. Faisal SM, Yan W, McDonough SP, Chang CF, Pan MJ, Chang YF. Leptosome-entrapped leptospiral antigens conferred significant higher levels of protection than those entrapped with PC-liposomes in a hamster model. Vaccine 2009, 27(47):6537-6545. 10.1016/j.vaccine.2009.08.051, 19729088.
25. Habarta A, Abreu PA, Olivera N, Hauk P, Cedola MT, Ferrer MF, Ho PL, Gomez RM. Increased Immunogenicity to LipL32 of Leptospira interrogans when Expressed as a Fusion Protein with the Cholera Toxin B Subunit. Curr Microbiol 2010,
26. Ko AI, Goarant C, Picardeau M. Leptospira: the dawn of the molecular genetics era for an emerging zoonotic pathogen. Nat Rev Microbiol 2009, 7(10):736-747. 10.1038/nrmicro2208, 19756012.
27. Matsunaga J, Barocchi MA, Croda J, Young TA, Sanchez Y, Siqueira I, Bolin CA, Reis MG, Riley LW, Haake DA, et al. Pathogenic Leptospira species express surface-exposed proteins belonging to the bacterial immunoglobulin superfamily. Mol Microbiol 2003, 49(4):929-945. 10.1046/j.1365-2958.2003.03619.x, 1237129, 12890019.
28. Palaniappan RU, Chang YF, Jusuf SS, Artiushin S, Timoney JF, McDonough SP, Barr SC, Divers TJ, Simpson KW, McDonough PL, et al. Cloning and molecular characterization of an immunogenic LigA protein of Leptospira interrogans. Infect Immun 2002, 70(11):5924-5930. 10.1128/IAI.70.11.5924-5930.2002, 130282, 12379666.
29. Seixas FK, Fernandes CH, Hartwig DD, Conceicao FR, Aleixo JA, Dellagostin OA. Evaluation of different ways of presenting LipL32 to the immune system with the aim of developing a recombinant vaccine against leptospirosis. Can J Microbiol 2007, 53(4):472-479. 10.1139/W06-138, 17612601.
30. Daly R, Hearn MT. Expression of heterologous proteins in Pichia pastoris: a useful experimental tool in protein engineering and production. J Mol Recognit 2005, 18(2):119-138. 10.1002/jmr.687, 15565717.
31. Montesino R, Garcia R, Quintero O, Cremata JA. Variation in N-linked oligosaccharide structures on heterologous proteins secreted by the methylotrophic yeast Pichia pastoris. Protein Expr Purif 1998, 14(2):197-207. 10.1006/prep.1998.0933, 9790882.
32. Goochee CF, Monica T. Environmental effects on protein glycosylation. Biotechnology (NY) 1990, 8(5):421-427.
33. Jenkins N, Parekh RB, James DC. Getting the glycosylation right: implications for the biotechnology industry. Nat Biotechnol 1996, 14(8):975-981. 10.1038/nbt0896-975, 9631034.
34. Ko AI, Galvao Reis M, Ribeiro Dourado CM, Johnson WD, Riley LW. Urban epidemic of severe leptospirosis in Brazil. Salvador Leptospirosis Study Group. Lancet 1999, 354(9181):820-825. 10.1016/S0140-6736(99)80012-9, 10485724.
35. Sambrook J, Russell DW. Molecular Cloning: A Laboratory Manual. 2000, Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 3.